CGC | Canopy Growth Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.49 - 3.82
52 Week Range	2.7550 - 14.92
Beta	0.61
Implied Volatility	93.49%
IV Rank	10.50%
Day's Volume	4,102,026
Average Volume	5,235,728
Shares Outstanding	127,837,015
Market Cap	450,625,478
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2014-04-07

Valuation
Profitability
Growth
Health
P/E Ratio	-0.69
Forward P/E Ratio	N/A
EPS	-5.08
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1,029
Country	Canada
Website	CGC

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

CGC's peers: ACB, FOLD, FATE, ABCL, CORT, MDRX, ALHC, ARVN, TLRY, PTCT, BEAM, CRON, ZOM, OGI, SNDL, TEVA

*Chart delayed

Analyzing fundamentals for CGC we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see CGC Fundamentals page.

Watching at CGC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on CGC Technicals page.